Related references
Note: Only part of the references are listed.Chelation of Extracellular Calcium-Induced Cell Death was Prevented by Glycogen Synthase Kinase-3 Inhibitors in PC12 Cells
Tsuneo Takadera et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity
Sungchan Cho et al.
GENES & DEVELOPMENT (2010)
Regulation of protein stability by GSK3 mediated phosphorylation
Chong Xu et al.
CELL CYCLE (2009)
A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog
Justin K. Ichida et al.
CELL STEM CELL (2009)
p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR
Faraz Farooq et al.
HUMAN MOLECULAR GENETICS (2009)
Regulation of SMN Protein Stability
Barrington G. Burnett et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Baozhi Chen et al.
NATURE CHEMICAL BIOLOGY (2009)
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Arthur H. M. Burghes et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Valproic acid blocks excitability in SMA type I mouse motor neurons
Kristen Rak et al.
NEUROBIOLOGY OF DISEASE (2009)
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing
Zhenxi Zhang et al.
CELL (2008)
Neurodevelopmental abnormalities in neurosphere-derived neural stem cells from SMN-depleted mice
Dina Shafey et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Inactivation of the SMN complex by oxidative stress
Lili Wan et al.
MOLECULAR CELL (2008)
A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy
Nguyen thi Man et al.
NEUROLOGY (2008)
Modeling Spinal Muscular Atrophy in Drosophila
Howard Chia-Hao Chang et al.
PLOS ONE (2008)
Where in the cell is the minor spliceosome?
Joan A. Steitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Minor spliceosome components are predominantly localized in the nucleus
Heli K. J. Pessa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Splicing segregation:: The minor spliceosome acts outside the nucleus and controls cell proliferation
Harald Koenig et al.
CELL (2007)
Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy
Sibylle Jablonka et al.
JOURNAL OF CELL BIOLOGY (2007)
Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approach
Allen W. Dodson et al.
VIROLOGY (2007)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts
Virginia B. Mattis et al.
HUMAN GENETICS (2006)
Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons
Honglai Zhang et al.
JOURNAL OF NEUROSCIENCE (2006)
Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology
D Shafey et al.
EXPERIMENTAL CELL RESEARCH (2005)
Digitalis: new actions for an old drug
JA Wasserstrom et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Glycogen synthase kinase 3β inhibits myocardin dependent transcription and hypertrophy induction through site-specific phosphorylation
C Badorff et al.
CIRCULATION RESEARCH (2005)
Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy
J Jarecki et al.
HUMAN MOLECULAR GENETICS (2005)
SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
TT Le et al.
HUMAN MOLECULAR GENETICS (2005)
Structure-aided optimization of kinase inhibitors derived from alsterpaullone
C Kunick et al.
CHEMBIOCHEM (2005)
Characterization of the neutralizing activity of digoxin-specific fab toward ouabain-like steroids
MA Pullen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin/proteasome pathway
HC Chang et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
W Rossoll et al.
JOURNAL OF CELL BIOLOGY (2003)
Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding
ML McWhorter et al.
JOURNAL OF CELL BIOLOGY (2003)
Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential
T Lahusen et al.
MOLECULAR CARCINOGENESIS (2003)
Directed differentiation of embryonic stem cells into motor neurons
H Wichterle et al.
CELL (2002)
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
C Andreassi et al.
HUMAN MOLECULAR GENETICS (2001)
Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
G Pearson et al.
ENDOCRINE REVIEWS (2001)
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
XJ Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
